Picture of Owlet logo

OWLT — Owlet News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousSmall CapNeutral

Owlet's Q2 revenue beats analyst estimates, announces CEO transition

Overview

Owlet Q2 revenue grows 25.9% yr/yr, beating analyst expectations, per LSEG data

Co announces CEO transition with Jonathan Harris succeeding Kurt Workman

Outlook

Owlet expects 2025 revenue between $97 mln and $100 mln

Company anticipates 2025 gross margins of 46% to 50%

Result Drivers

PRODUCT SALES - Higher sales of Dream Sock and Dream Duo products drove revenue growth

GROSS MARGIN IMPROVEMENT - Gross margin increased due to favorable product mix and lower costs

SUBSCRIPTION GROWTH - Owlet360 subscription surpassed 66,000 paying subscribers, boosting recurring revenue

Key Details

MetricBeat/MissActualConsensus Estimate
Q2 RevenueBeat$26.10 mln$22.20 mln (4 Analysts)
Q2 Adjusted EPSBeat-$0.05-$0.22 (3 Analysts)
Q2 EPS-$2.37
Q2 Gross Margin51.3%
Q2 Operating Expenses$15.30 mln
Analyst Coverage The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy", no "hold" and no "sell" or "strong sell" The average consensus recommendation for the advanced medical equipment & technology peer group is "buy" Wall Street's median 12-month price target for Owlet Inc is $11.50, about 38.3% above its August 6 closing price of $7.10 Press Release: ID:nBw8HX093a (This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Recent news on Owlet

See all news